Agilisium Achieves Prestigious Amaz on Web Services (AWS) Life Sciences Comp etency status
~This recognition makes the company o ne of the 28 consulting partners with A WS Life Sciences Competency Status o ut of the 8300+ AWS Partners globally~
Chennai, 30th July, 2024: Agilisium, a pi oneering leader in Data Analytics, Clou d, and Life Science solutions, today ann ounced that it has won the coveted AW S Life Sciences Competency status; placi ng the brand among an exclusive group of 28 Consulting Partners out of 8,300+ AWS Partners globally.
This rem arkable achievement demonstr ates th e company’s proven expertise in deliv ering transformative cloud solutio ns t o pharmaceutical companies, seekin g to expedite drug discovery, strengthen clinical trials, and develop novel genet i c-based treatments.
Agilisium has developed over 20 GenA I-powered data analytics solutions exe mplifying the company’s innovative ap proach, enabling pharma organisation ons to unlock deeper insights, and acce lerate research and development cycle s; thereby bringing life-saving treatme nts to patients more efficiently. Furthe rmore, Agilisium’s solutions and accel erators can be accessed through the A WS marketplace.
Commenting on the achievement, Mr Ra j Babu, Founder and CEO of Agilisium sa id, “Earning the AWS Life Sciences Com petency status is a significant mile st mo ne for Agilisium. This achievement refle cts our team’s unwavering ded ication to understanding the complex challenges in the pharma industry and developing solutions that effectively a ddress them. By harnessing the power of our GenAI solutions, we are confide nt that we can usher in a new era of da ta-driven discov ery and innovation in life sciences. Addit ionally, this recogn ition would enable o ur clients to tran sform data into meanin gful insights, u ltimately delivering life-c hanging the rapies to patients faster, glo bally”.
As one of the few AWS-certified Data A nalytics partners with specialized exper tise in the pharmaceutical industry, Agil isium is uniquely positioned to of fer a w ide range of AWS services tailor ed for t he Life Sciences industry. This includes g enerative AI solutions, adva nced analyt ics, data lakes, and machi ne learning,am ong several others. The company also of fers AWS’ MAP (Migra tion Acceleration Program) funding pr ogram and No-Cost Assessment progra m for its clients whic h significantly he lps clients to accelerat e faster Cloud Transformation journeys.
About Agilisium –
Agilisium is one of the premier Life Sci ences partners for digital innovations. The company delivers cutting-edge sol utions that drive impactful change by combining our strong domain experti rtise with Data, Cloud, GenAI, and Adv anced Analytics. Agilisium collaborate s with leading pharma and biotech comp anies to provide data-driven insigh ts an d innovative solutions across the value chain, helping accelerate drug discovery , optimize patient care, achiev e commer cial success, streamline pro duct delive ry, and foster collaboration . The compa ny’s commitment to rigoro us execution and continuous innovatio tion enables it to shape the future of th e Life Sciences industry.
Website: www.agilisium.com
